PENTAIR plc — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that PENTAIR plc filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $755.20M | Feb 25, 2020 |
| FY2019 | Sep 30, 2019 | $713.60M | Feb 25, 2020 |
| FY2019 | Jun 30, 2019 | $799.50M | Feb 25, 2020 |
| FY2019 | Mar 31, 2019 | $688.90M | Feb 25, 2020 |
| FY2019 | Dec 31, 2018 | $740.50M | Feb 25, 2020 |
| FY2019 | Sep 30, 2018 | $711.40M | Feb 25, 2020 |
| FY2019 | Jun 30, 2018 | $780.60M | Feb 25, 2020 |
| FY2019 | Mar 31, 2018 | $732.60M | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $720.80M | Feb 19, 2019 |
| FY2018 | Sep 30, 2017 | $687.60M | Feb 19, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.18B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $4.08B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $4.10B | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $4.12B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $3.76B | Feb 20, 2024 |
| FY2020 | Dec 31, 2020 | $796.00M | Feb 16, 2021 |
| FY2020 | Sep 30, 2020 | $798.50M | Feb 16, 2021 |
| FY2020 | Jun 30, 2020 | $713.30M | Feb 16, 2021 |
| FY2020 | Mar 31, 2020 | $710.00M | Feb 16, 2021 |
| FY2020 | Dec 31, 2019 | $755.20M | Feb 16, 2021 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $1.26B | Feb 27, 2018 |
| FY2017 | Sep 30, 2017 | $1.23B | Feb 27, 2018 |
| FY2017 | Jun 30, 2017 | $1.27B | Feb 27, 2018 |
| FY2017 | Mar 31, 2017 | $1.18B | Feb 27, 2018 |
| FY2017 | Dec 31, 2016 | $1.19B | Feb 27, 2018 |
| FY2017 | Sep 30, 2016 | $1.21B | Feb 27, 2018 |
| FY2017 | Jun 30, 2016 | $1.30B | Feb 27, 2018 |
| FY2017 | Mar 31, 2016 | $1.19B | Feb 27, 2018 |
| FY2016 | Dec 31, 2015 | $1.29B | Feb 21, 2017 |
| FY2016 | Sep 26, 2015 | $1.11B | Feb 21, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.69B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $1.60B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $1.52B | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $1.36B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $1.32B | Feb 20, 2024 |
| FY2020 | Dec 31, 2020 | $283.50M | Feb 16, 2021 |
| FY2020 | Sep 30, 2020 | $277.40M | Feb 16, 2021 |
| FY2020 | Jun 30, 2020 | $245.10M | Feb 16, 2021 |
| FY2020 | Mar 31, 2020 | $251.60M | Feb 16, 2021 |
| FY2020 | Dec 31, 2019 | $274.20M | Feb 16, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $653.80M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $625.40M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $622.70M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $480.90M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $553.00M | Feb 20, 2024 |
| FY2020 | Dec 31, 2020 | $103.00M | Feb 16, 2021 |
| FY2020 | Sep 30, 2020 | $110.80M | Feb 16, 2021 |
| FY2020 | Jun 30, 2020 | $72.10M | Feb 16, 2021 |
| FY2020 | Mar 31, 2020 | $72.70M | Feb 16, 2021 |
| FY2020 | Dec 31, 2019 | $97.80M | Feb 16, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $857.50M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $803.80M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $739.20M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $595.30M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $636.90M | Feb 20, 2024 |
| FY2020 | Dec 31, 2020 | $121.50M | Feb 16, 2021 |
| FY2020 | Sep 30, 2020 | $128.10M | Feb 16, 2021 |
| FY2020 | Jun 30, 2020 | $111.10M | Feb 16, 2021 |
| FY2020 | Mar 31, 2020 | $100.70M | Feb 16, 2021 |
| FY2020 | Dec 31, 2019 | $122.30M | Feb 16, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $95.90M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $93.60M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $99.80M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $92.20M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $85.90M | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $75.70M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $78.90M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $76.70M | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $73.20M | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $73.30M | Feb 19, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $736.90M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $701.40M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $680.20M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $677.10M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $596.40M | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $520.50M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $540.10M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $534.30M | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $536.00M | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $531.40M | Feb 19, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $814.80M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $766.70M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $619.20M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $363.30M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $613.20M | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $573.60M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $353.00M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $439.10M | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $620.20M | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $861.40M | Feb 19, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $68.80M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $74.40M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $76.00M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $85.20M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $60.20M | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $62.20M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $58.50M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $48.20M | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $39.10M | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $43.30M | Feb 19, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.87B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $6.45B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $6.56B | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $6.45B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $4.75B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $4.20B | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $4.14B | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $3.81B | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $8.63B | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $11.53B | Feb 19, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.00B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $2.88B | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $3.35B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $3.74B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $2.33B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $2.09B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $2.19B | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $1.97B | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $3.60B | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $7.28B | Feb 27, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $4.66B | Feb 24, 2015 |
| FY2014 | Dec 31, 2013 | $6.10B | Feb 24, 2015 |
| FY2013 | Dec 31, 2012 | $6.37B | Feb 25, 2014 |
| FY2012 | Dec 31, 2011 | $1.93B | Feb 26, 2013 |
| FY2011 | Dec 31, 2010 | $2.09B | Apr 13, 2012 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.54B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $3.29B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $3.27B | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $3.25B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $2.50B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $2.39B | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $2.26B | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $2.07B | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $2.11B | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $1.99B | Feb 19, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.82B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $2.34B | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $1.87B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $1.39B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $1.05B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $631.20M | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $401.00M | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $169.20M | Feb 25, 2020 |
| FY2018 | Jan 1, 2018 | $2.27B | Feb 19, 2019 |
| FY2018 | Dec 31, 2017 | $2.48B | Feb 19, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $82.50M | Feb 25, 2020 |
| FY2019 | Dec 31, 2018 | $74.30M | Feb 25, 2020 |
| FY2019 | Dec 31, 2017 | $86.30M | Feb 25, 2020 |
| FY2019 | Dec 31, 2016 | $216.90M | Feb 25, 2020 |
| FY2018 | Dec 31, 2015 | $103.60M | Feb 19, 2019 |
| FY2018 | Dec 31, 2014 | $103.60M | Feb 19, 2019 |
| FY2016 | Dec 31, 2013 | $256.00M | Feb 21, 2017 |
| FY2015 | Dec 31, 2012 | $237.40M | Feb 26, 2016 |
| FY2014 | Dec 31, 2011 | $50.10M | Feb 24, 2015 |
| FY2013 | Dec 31, 2010 | $46.10M | Feb 25, 2014 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.64B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $1.64B | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $1.99B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $2.32B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $894.10M | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $839.60M | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $1.03B | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $787.60M | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $1.44B | Feb 19, 2019 |
| FY2016 | Dec 31, 2016 | $4.30B | Feb 21, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | 3 | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 20, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 16, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 16, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 16, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 16, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 16, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | 3 | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 20, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 16, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 16, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 16, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 16, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 16, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | Dec 31, 2011 | 98.62M | Feb 21, 2012 |
| FY2010 | Dec 31, 2010 | 98.41M | Feb 23, 2011 |
| FY2010 | Dec 31, 2009 | 98.66M | Feb 23, 2011 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $164.30M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $152.30M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $145.20M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $138.60M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $133.00M | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $127.10M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $122.70M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $187.20M | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $251.70M | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $243.60M | Feb 19, 2019 |